SCHEMBL948729

SCHEMBL948729

CC1=NC(c2cccc(-c3cc(Cl)cc(Cl)c3)c2)(c2cnn(C)c2C)N=C1

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.42
BACE2 Q9Y5Z0 2/20 0.34
KCNH2 Q12809 1/20 0.34
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
CTSD P07339 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945531 0.82 BACE1 (0.51) BACE1BACE2KCNH2
SCHEMBL946334 0.76 BACE1 (0.52) BACE1BACE2KCNH2
SCHEMBL943868 0.66 BACE1 (0.64) BACE1BACE2KCNH2
SCHEMBL945976 0.63 BACE1 (0.46) BACE1BACE2KCNH2CTSD
SCHEMBL945166 0.61 BACE1 (0.45) BACE1BACE2KCNH2
SCHEMBL4237892 0.61 BACE1 (0.88) BACE1
SCHEMBL12225753 0.60 RXRA (0.50)
SCHEMBL8240837 0.59 BACE1 (0.81) BACE1BACE2CTSD
SCHEMBL7526262 0.58 BACE1 (0.49) BACE1
SCHEMBL10121036 0.58 BACE1 (0.46) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO claimed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed